{"id":16151,"date":"2020-08-12T11:49:58","date_gmt":"2020-08-12T06:49:58","guid":{"rendered":"https:\/\/www.vosa.tv\/?p=16151"},"modified":"2020-08-12T11:49:58","modified_gmt":"2020-08-12T06:49:58","slug":"who-cautions-russia-on-covid-19-vaccine","status":"publish","type":"post","link":"https:\/\/www.vosa.tv\/eng\/archives\/16151","title":{"rendered":"WHO cautions Russia on COVID-19 vaccine"},"content":{"rendered":"<p><strong>GENEVA<\/strong><\/p>\n<p>The World Health Organization (WHO) said Tuesday it is following Russia\u2019s progress in developing a COVID-19 vaccine, but cautioned that progress in fight against the virus should not compromise on safety.<\/p>\n<p>Commenting on Russian President Vladimir Putin&#8217;s earlier announcement that Russia had registered the world\u2019s first coronavirus vaccine at a UN press briefing, a WHO spokesman said the &#8220;pandemic is threatening lives and economies.\u201d<\/p>\n<p>\u201cIt\u2019s vital that we apply all public health measures that we know are working, and we need to continue to invest in and accelerate the development of safe and effective treatments and vaccines that will help us reduce disease transmission in the future,\u201d said spokesman Tarik Jasarevic in answer to a question by Anadolu Agency.<\/p>\n<p>The vaccine, developed by the Gamaleya National Research Center, has officially been registered with Russia\u2019s Health Ministry, Putin told a meeting of members of the government in Moscow.<\/p>\n<p>\u201cWe are in close contact with the Russian health authorities, and discussions are going on with respect to possible pre-qualification of the vaccine,&#8221; he noted, adding pre-qualification of any vaccine needs rigorous review and assessment.<\/p>\n<p>He said as soon as the \u201cabsolutely essential clinical trial data\u201d is available, national regulatory bodies need to be ready to review the safety and efficacy data before using it.<\/p>\n<p>\u201cWe are following the progress in the development of COVID-19 vaccines, and we maintain the draft landscape of candidate vaccines, which is updated every week on our website,\u201d said the spokesman. \u201cWHO lists 25 candidate vaccines in clinical evaluation and 139 in a pre-clinical evaluation.\u201d<\/p>\n<p>Jasarevic said the WHO has its accelerator program seeking to speed up research for an effective vaccine for all countries. \u201cAt the same time, we are supporting the building of manufacturing capabilities and buying supplies ahead of time so that we have doses that could be equitably distributed in 2021,\u201d he said.<\/p>\n<p>Earlier\u00a0 on\u00a0 Wednesday, President Vladmir Putin announce that Russia invent\u00a0 the vaccine for corona virus and pass all\u00a0 clinical trials.\u00a0 Russia was ready for distribution of the vaccine to the world.<\/p>\n<p>Johns Hopkins University Corona virus Resources Center said Tuesday that the world has 20,113,592 confirmed COVID-19 cases, with 737,022 deaths recorded and more than 12 million recoveries. With 895,691 cases, Russia has the world\u2019s fourth-highest COVID-19 case tally.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>GENEVA The World Health Organization (WHO) said Tuesday it is following Russia\u2019s progress in developing a COVID-19 vaccine, but cautioned that progress in fight against the virus should not compromise on safety. Commenting on Russian President Vladimir Putin&#8217;s earlier announcement that Russia had registered the world\u2019s first coronavirus vaccine at a UN press briefing, a [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":14112,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,1472,37],"tags":[],"class_list":["post-16151","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","category-russia","category-world"],"_links":{"self":[{"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/posts\/16151","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/comments?post=16151"}],"version-history":[{"count":1,"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/posts\/16151\/revisions"}],"predecessor-version":[{"id":16152,"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/posts\/16151\/revisions\/16152"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/media\/14112"}],"wp:attachment":[{"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/media?parent=16151"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/categories?post=16151"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/tags?post=16151"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}